1.Induction and Expression of Chemokines and Their Receptors in Human Mast Cell Line ( HMC - 1 ).
Korean Journal of Immunology 1999;21(4):335-342
The mast cell is an essential effector cell in allergic inflammation through its capacity to respond to IgE dependent activation. Mast cells also participate in the modulation of physiologic processes, but the role of mast cell in these processes is still unclear. Recently, the number of structurally defined chernoattractants for leukocytes has greatly increased, owing to largely to the identification of the chemokine superfamily. In this study we examined the pattern of expression of chemokines and their receptors in HMC-1 after treatment with PMA/A23187 and/or LPS using RT-PCR and ELISA. Messenger RNA of IL-8, the representative CXC chemokine, was induced after PMA/ A23187 treatment. All of the CC chemokines tested, except eotaxin, were induced after PMA/A23187 treatment. CCR1, CXCR2, CXCR3 and CXCR4 were expressed in all test groups regardless of activation. CCR3 was expressed only at 3 hours of activation. CCR2, CCR5 and CXCR1 were not expressed in mast cell line. Production of most of chemokine proteins was not detected in resting state and increased significantly after 3 hours of activation with PMA/A23187. The effect of LPS treatment was negligible. MCP-1 protein was always produced without activation and accurnulated in a time-dependent rnanner. These data suggest that the expression of mRNA and protein of chemokines and chemokine receptors are regulated transcriptionally and translationally. Human mast cell may respond to various stimuli by producing chemokines and their receptors to regulate their function and may act autonomously or through other inflammatory cell that they recruited.
Calcimycin
;
Chemokines*
;
Chemokines, CC
;
Enzyme-Linked Immunosorbent Assay
;
Humans*
;
Immunoglobulin E
;
Inflammation
;
Interleukin-8
;
Leukocytes
;
Mast Cells*
;
Receptors, Chemokine
;
RNA, Messenger
2.Identification of Inducible Murine Mast Cell Genes by Suppression PCR - Based Subtractive Hybridization.
Korean Journal of Immunology 1999;21(4):327-334
The mast cell is an essential effector cell in allergic inflammation through its capacity to respond to IgE dependent activation. Mast cells also participate in the modulation of physiologic processes, but the role of mast cell in these processes is still unclear. Recently, the number of structurally defined chernoattractants for leukocytes has greatly increased, owing to largely to the identification of the chemokine superfamily. In this study we examined the pattern of expression of chemokines and their receptors in HMC-1 after treatment with PMA/A23187 and/or LPS using RT-PCR and ELISA. Messenger RNA of IL-8, the representative CXC chemokine, was induced after PMA/ A23187 treatment. All of the CC chemokines tested, except eotaxin, were induced after PMA/A23187 treatment. CCR1, CXCR2, CXCR3 and CXCR4 were expressed in all test groups regardless of activation. CCR3 was expressed only at 3 hours of activation. CCR2, CCR5 and CXCR1 were not expressed in mast cell line. Production of most of chemokine proteins was not detected in resting state and increased significantly after 3 hours of activation with PMA/A23187. The effect of LPS treatment was negligible. MCP-1 protein was always produced without activation and accurnulated in a time-dependent rnanner. These data suggest that the expression of mRNA and protein of chemokines and chemokine receptors are regulated transcriptionally and translationally. Human mast cell may respond to various stimuli by producing chemokines and their receptors to regulate their function and may act autonomously or through other inflammatory cell that they recruited.
Calcimycin
;
Chemokines
;
Chemokines, CC
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunoglobulin E
;
Inflammation
;
Interleukin-8
;
Leukocytes
;
Mast Cells*
;
Polymerase Chain Reaction*
;
Receptors, Chemokine
;
RNA, Messenger
3.Production of human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus transformation.
Seung Min YOO ; Jeong Je CHO ; Soon Tae HO ; Youn Mun HA
Korean Journal of Immunology 1993;15(2):139-146
No abstract available.
Antibodies, Monoclonal*
;
Herpesvirus 4, Human*
;
Humans*
;
Tetanus Toxoid*
;
Tetanus*
4.Cloning of Mouse Pleckstrin 1 from Mast Cell Subtraction Library.
Young Baik HAM ; Hyun Jong AHN ; Youn Mun HA ; Jeong Je CHO
Korean Journal of Immunology 2000;22(4):265-273
No abstract available.
Animals
;
Clone Cells*
;
Cloning, Organism*
;
Mast Cells*
;
Mice*
5.S Antigen Specific Rat Helper T Cell Line Induced Experimental Autoimmune Uveoretinitis.
Youn Mun HA ; Soon Tae HO ; Jeong Je CHO ; Seung Min YOO
Korean Journal of Immunology 1997;19(2):181-188
No abstract available.
Adaptive Immunity
;
Animals
;
Cell Line*
;
Rats*
6.Production of monoclonal antibody to Epstein-Barr virus antigen.
Jeong Je CHO ; Soon Tae HO ; Seung Min YOO ; Youn Mun HA
Korean Journal of Immunology 1992;14(1):117-131
No abstract available.
Herpesvirus 4, Human*
7.A Case of the Uterus Didelphys with Unilateral Obstructed Hemivagina.
Moon Hee YOUN ; Min Jung KWAK ; Ji Uen KIM ; Mun Geon JANG ; Seon Ha JOO ; Keon JIN
Korean Journal of Obstetrics and Gynecology 2004;47(8):1620-1624
Uterus didelphys with unilateral obstructed hemivagina is indeed a very rare congenital anomaly due to M llerian duct malformation. The most common clinical presentation is pelvic pain and dysmenorrhea shortly after menarche, in associated with the finding of a vaginal or pelvic mass. An accurate and prompt diagnosis is of importance to permit treatment and to assure the future fertility of the patient. The simple and adequate treatment of the condition is incision of the obstructed vaginal septum providing adequate drainage of the retained blood. We report a case of uterus didelphys with obstructed hemivagina with brief review of the literature.
Diagnosis
;
Drainage
;
Dysmenorrhea
;
Female
;
Fertility
;
Humans
;
Menarche
;
Pelvic Pain
;
Uterus*
8.Generation of monoclonal antibodies reactive to human interleukin 2(IL 2).
Youn Mun HA ; Jun Hyung LEE ; Seung Min YOO ; Jeong Je CHO ; Soon Tae HO ; Jae Kyung PARK ; Sang Yun NAM
Journal of the Korean Society for Microbiology 1993;28(4):313-319
No abstract available.
Antibodies, Monoclonal*
;
Humans*
;
Interleukins*